ConductScience.org, home

Paper730378

Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii.

Wachter RF and 2 others. Infect Immun, 1978. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii. Papers, record 730378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/730378

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii.
PubMed
Journal
Infect Immun
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.26
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wachter RFR F
2Briggs GPG P
3Pedersen CE JrC E

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, BacterialMajor topic
Antigens, BacterialMajor topic
CoxiellaMajor topic
Animals
Bacterial Vaccines
Carboxymethylcellulose Sodium
Guinea Pigs
Poly I-C
Polylysine
Q Fever

Source PubMed

Download CSV of topics

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114482335Antigens of Coxiella burnetii. I. Extraction of antigens with non-aqueous organic solvents.J Immunol1962https://conductscience.org/library/papers/14482335PubMed
2408923Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys.Science1977https://conductscience.org/library/papers/408923PubMed
3407312Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta).J Infect Dis1977https://conductscience.org/library/papers/407312PubMed
4820645Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant.Infect Immun1976https://conductscience.org/library/papers/820645PubMed
54102398Regulation of the immune system by synthetic polynucleotides. I. Characteristics of adjuvant action on antibody synthesis.J Immunol1971https://conductscience.org/library/papers/4102398PubMed
64755168Immunization in man with a soluble Q fever vaccine.Arch Roum Pathol Exp Microbiol1973https://conductscience.org/library/papers/4755168PubMed
7970938Preparation of phase 1Q fever antigen suitable for vaccine use.Appl Environ Microbiol1976https://conductscience.org/library/papers/970938PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn Papers
18701647Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii.Clin Vaccine Immunol2008https://conductscience.org/library/papers/18701647

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/730378

GET https://conductscience.org/api/papers/v1/730378/authors